Orgenesis - Stock Price History | ORGS
Historical daily share price chart and data for Orgenesis since 2021 adjusted for splits. The latest closing stock price for Orgenesis as of September 27, 2021 is 5.02.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
- The all-time high Orgenesis stock closing price was 14.68 on March 15, 2018.
- The Orgenesis 52-week high stock price is 8.30, which is 65.3% above the current share price.
- The Orgenesis 52-week low stock price is 4.14, which is 17.5% below the current share price.
- The average Orgenesis stock price for the last 52 weeks is 5.34.
|Orgenesis Historical Annual Stock Price Data
||Average Stock Price
||Annual % Change
||Medical - Biomedical and Genetics
Orgenesis, Inc. is a biopharmaceutical company. It focused on developing its trans-differentiation technologies for diabetes. The company deals with the combination of cell-based therapy and regenerative medicine into clinical development. Its operating segment consists of Contract Development and Manufacturing Organization and Cellular Therapy Business. Contract Development and Manufacturing Organization segment activity includes MaSTherCell, which specializes in cell therapy development for advanced medicinal products. Cellular Therapy Business segment activity is based on its technology which demonstrates the capacity to induce a shift in the developmental fate of cells from the liver and differentiating them into pancreatic beta cell like insulin producing cells for patients with Type 1 Diabetes. Orgenesis, Inc. is headquartered in Germantown, MD.